Brian Williams

Recent research has uncovered exciting findings about the lasting effects of psilocybin, a powerful psychedelic compound known for its ability to alter brain function and behaviour. A study conducted by researchers using advanced neuroimaging techniques explored whether psilocybin causes enduring changes to the brain’s structure and functioning, particularly in terms of cognitive flexibility, psychological insight, […]

A systematic review and meta-analysis published in The BMJ today suggests that high doses of psilocybin, the active compound in magic mushrooms, may have similar effects on depressive symptoms as the selective serotonin reuptake inhibitor (SSRI) drug escitalopram (sold under brand names such as Lexapro and Cipralex). The analysis found that patients treated with high

Microdosing magic mushrooms has gained popularity recently as a method for exploring the potential benefits of psilocybin, the active compound in these fungi. This practice, often associated with enhanced creativity, improved mood, and increased focus, has drawn the attention of many individuals seeking alternative ways to improve their mental well-being. This article will delve into